Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study
- PMID: 37221465
- PMCID: PMC10204198
- DOI: 10.1186/s12879-023-08329-2
Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study
Abstract
Background: Little evidence exists regarding the prevalence of pathogens in bloodstream infections (BSIs), the mortality risk, and the benefit of combination therapy over monotherapy. This study aims to describe patterns of empiric antimicrobial therapy, and the epidemiology of Gram-negative pathogens, and to investigate the effect of appropriate therapy and appropriate combination therapy on the mortality of patients with BSIs.
Methods: This was a retrospective cohort study including all patients with BSIs of Gram-negative pathogens from January 2017 to December 2022 in a Chinese general hospital. The in-hospital mortality was compared between appropriate and inappropriate therapy, and between monotherapy and combination therapy for patients receiving appropriate therapy. We used Cox regression analysis to identify factors independently associated with in-hospital mortality.
Results: We included 205 patients in the study, of whom 147 (71.71%) patients received appropriate therapy compared with 58 (28.29%) who received inappropriate therapy. The most common Gram-negative pathogen was Escherichia coli (37.56%). 131 (63.90%) patients received monotherapy and 74 (36.10%) patients received combination therapy. The in-hospital mortality was significantly lower in patients administered appropriate therapy than inappropriate therapy (16.33% vs. 48.28%, p = 0.004); adjusted hazard ratio [HR] 0.55 [95% CI 0.35-0.84], p = 0.006). In-hospital mortality was also not different in combination therapy and monotherapy in the multivariate Cox regression analyses (adjusted HR 0.42 [95% CI 0.15-1.17], p = 0.096). However, combination therapy was associated with lower mortality than monotherapy in patients with sepsis or septic shock (adjusted HR 0.94 [95% CI 0.86-1.02], p = 0.047).
Conclusions: Appropriate therapy was associated with a protective effect on mortality among patients with BSIs due to Gram-negative pathogens. Combination therapy was associated with improved survival in patients with sepsis or septic shock. Clinicians need to choose optical empirical antimicrobials to improve survival outcomes in patients with BSIs.
Keywords: Appropriate empirical antimicrobial therapy; Bloodstream infections; Mortality.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US.JAMA Netw Open. 2023 Jan 3;6(1):e2249353. doi: 10.1001/jamanetworkopen.2022.49353. JAMA Netw Open. 2023. PMID: 36598788 Free PMC article.
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.Lancet Infect Dis. 2017 Jul;17(7):726-734. doi: 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22. Lancet Infect Dis. 2017. PMID: 28442293
-
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.Antimicrob Agents Chemother. 2010 May;54(5):1742-8. doi: 10.1128/AAC.01365-09. Epub 2010 Feb 16. Antimicrob Agents Chemother. 2010. PMID: 20160050 Free PMC article.
-
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.Crit Care Med. 2014 Nov;42(11):2342-9. doi: 10.1097/CCM.0000000000000516. Crit Care Med. 2014. PMID: 25072764
-
Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.Semin Respir Crit Care Med. 2015 Feb;36(1):154-66. doi: 10.1055/s-0034-1398742. Epub 2015 Feb 2. Semin Respir Crit Care Med. 2015. PMID: 25643278 Review.
Cited by
-
Antimicrobial Stewardship Impact on Antibiotic Use in Three Tertiary Hospitals in Zambia: A Comparative Point Prevalence Survey.Antibiotics (Basel). 2025 Mar 10;14(3):284. doi: 10.3390/antibiotics14030284. Antibiotics (Basel). 2025. PMID: 40149095 Free PMC article.
-
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study.J Antimicrob Chemother. 2024 Aug 1;79(8):2053-2061. doi: 10.1093/jac/dkae211. J Antimicrob Chemother. 2024. PMID: 38958258 Free PMC article.
-
Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study.Am J Trop Med Hyg. 2023 Sep 18;109(5):1095-1106. doi: 10.4269/ajtmh.22-0556. Print 2023 Nov 1. Am J Trop Med Hyg. 2023. PMID: 37722663 Free PMC article.
-
Difficult-to-treat resistant Pseudomonas aeruginosa infections in Lebanese hospitals: Impact on mortality and the role of initial antibiotic therapy.PLoS One. 2025 May 12;20(5):e0321935. doi: 10.1371/journal.pone.0321935. eCollection 2025. PLoS One. 2025. PMID: 40354447 Free PMC article.
-
Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.Clin Infect Dis. 2024 Oct 15;79(4):855-863. doi: 10.1093/cid/ciae282. Clin Infect Dis. 2024. PMID: 38758977 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical